Annual Working Capital
$204.70 M
-$80.84 M-28.31%
December 31, 2023
Summary
- As of March 10, 2025, RGNX annual working capital is $204.70 million, with the most recent change of -$80.84 million (-28.31%) on December 31, 2023.
- During the last 3 years, RGNX annual working capital has fallen by -$245.05 million (-54.49%).
- RGNX annual working capital is now -54.49% below its all-time high of $449.75 million, reached on December 31, 2020.
Performance
RGNX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$210.67 M
-$37.74 M-15.19%
September 30, 2024
Summary
- As of March 10, 2025, RGNX quarterly working capital is $210.67 million, with the most recent change of -$37.74 million (-15.19%) on September 30, 2024.
- Over the past year, RGNX quarterly working capital has stayed the same.
- RGNX quarterly working capital is now -53.16% below its all-time high of $449.75 million, reached on December 31, 2020.
Performance
RGNX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RGNX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.3% | 0.0% |
| 3 y3 years | -54.5% | 0.0% |
| 5 y5 years | -35.2% | 0.0% |
RGNX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.3% | at low | -45.8% | +2.9% |
| 5 y | 5-year | -54.5% | at low | -53.2% | +2.9% |
| alltime | all time | -54.5% | +3424.1% | -53.2% | +3521.1% |
REGENXBIO Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $210.67 M(-15.2%) |
| Jun 2024 | - | $248.41 M(-12.9%) |
| Mar 2024 | - | $285.24 M(+39.3%) |
| Dec 2023 | $204.70 M(-28.3%) | $204.70 M(-14.2%) |
| Sep 2023 | - | $238.49 M(-8.6%) |
| Jun 2023 | - | $260.92 M(-5.8%) |
| Mar 2023 | - | $276.87 M(-3.0%) |
| Dec 2022 | $285.54 M(-26.5%) | $285.54 M(-8.8%) |
| Sep 2022 | - | $313.09 M(-10.8%) |
| Jun 2022 | - | $350.87 M(+7.3%) |
| Mar 2022 | - | $326.94 M(-15.8%) |
| Dec 2021 | $388.35 M(-13.7%) | $388.35 M(+28.0%) |
| Sep 2021 | - | $303.39 M(-12.3%) |
| Jun 2021 | - | $345.83 M(-16.6%) |
| Mar 2021 | - | $414.68 M(-7.8%) |
| Dec 2020 | $449.75 M(+44.4%) | $449.75 M(+39.1%) |
| Sep 2020 | - | $323.34 M(+11.9%) |
| Jun 2020 | - | $288.88 M(-5.7%) |
| Mar 2020 | - | $306.44 M(-1.6%) |
| Dec 2019 | $311.36 M | $311.36 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $328.88 M(-1.8%) |
| Jun 2019 | - | $334.83 M(+18.5%) |
| Mar 2019 | - | $282.49 M(-10.5%) |
| Dec 2018 | $315.74 M(+105.6%) | $315.74 M(-14.0%) |
| Sep 2018 | - | $367.24 M(+32.9%) |
| Jun 2018 | - | $276.42 M(+11.5%) |
| Mar 2018 | - | $247.84 M(+61.4%) |
| Dec 2017 | $153.56 M(+83.5%) | $153.56 M(-3.3%) |
| Sep 2017 | - | $158.76 M(+2.9%) |
| Jun 2017 | - | $154.35 M(+11.2%) |
| Mar 2017 | - | $138.84 M(+65.9%) |
| Dec 2016 | $83.70 M(-26.5%) | $83.70 M(+1.8%) |
| Sep 2016 | - | $82.24 M(-7.3%) |
| Jun 2016 | - | $88.76 M(-11.1%) |
| Mar 2016 | - | $99.80 M(-12.3%) |
| Dec 2015 | $113.81 M(-1948.1%) | $113.81 M(-45.9%) |
| Sep 2015 | - | $210.18 M(+159.3%) |
| Jun 2015 | - | $81.05 M(-1416.2%) |
| Dec 2014 | -$6.16 M(+151.8%) | -$6.16 M |
| Dec 2013 | -$2.45 M | - |
FAQ
- What is REGENXBIO annual working capital?
- What is the all time high annual working capital for REGENXBIO?
- What is REGENXBIO annual working capital year-on-year change?
- What is REGENXBIO quarterly working capital?
- What is the all time high quarterly working capital for REGENXBIO?
- What is REGENXBIO quarterly working capital year-on-year change?
What is REGENXBIO annual working capital?
The current annual working capital of RGNX is $204.70 M
What is the all time high annual working capital for REGENXBIO?
REGENXBIO all-time high annual working capital is $449.75 M
What is REGENXBIO annual working capital year-on-year change?
Over the past year, RGNX annual working capital has changed by -$80.84 M (-28.31%)
What is REGENXBIO quarterly working capital?
The current quarterly working capital of RGNX is $210.67 M
What is the all time high quarterly working capital for REGENXBIO?
REGENXBIO all-time high quarterly working capital is $449.75 M
What is REGENXBIO quarterly working capital year-on-year change?
Over the past year, RGNX quarterly working capital has changed by $0.00 (0.00%)